New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

A symptom of COVID is the loss of taste or smell. Tuberculosis has a longer incubation period, and the symptoms have a much ...

TB infections have been rising every year since 2020 after 30 years of decline. Now, a historic outbreak in Kansas is ...

In a special report published in August 2024, the WHO added the three noninferior regimens from the endTB trial to the list of treatment options for rifampin-resistant and multidrug-resistant TB ...

New Jersey is experiencing a similar increase in cases and has a TB incidence rate above the national average. While TB isn’t ...

Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB: Gireesh Babu, New Delhi Monday, February 10, 2025, 08:00 Hrs [IST] A Parliamentary ...

Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-suscep ...